07-Oct-2026 18:04:54

NOVARTINDGeneral news

EVONILE PHARMA : CREDIT RATING ASSIGNED

• CARE Ratings Limited assigned CARE A; Stable to Long Term Bank Facilities and CARE A; Stable / CARE A2+ to Long Term / Short Term Bank Facilities. • The rating rationale is available on CARE Ratings Limited's website. • Information also available on the company's website: www.nilpharma.co.in. Impact: Credit rating outcome may influence future borrowing costs.

Novartis India Ltd

Open attachment

← Back to feed